L82-G17
CAS No. 92285-87-5
L82-G17( —— )
Catalog No. M28986 CAS No. 92285-87-5
L82-G17 is an uncompetitive LigI-selective inhibitor in human cells with utility as a probe of the catalytic activity and cellular functions of LigI.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 110 | Get Quote |
|
| 10MG | 178 | Get Quote |
|
| 25MG | 410 | Get Quote |
|
| 50MG | 605 | Get Quote |
|
| 100MG | 860 | Get Quote |
|
| 500MG | 1728 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameL82-G17
-
NoteResearch use only, not for human use.
-
Brief DescriptionL82-G17 is an uncompetitive LigI-selective inhibitor in human cells with utility as a probe of the catalytic activity and cellular functions of LigI.
-
DescriptionL82-G17 is an uncompetitive LigI-selective inhibitor in human cells with utility as a probe of the catalytic activity and cellular functions of LigI.
-
In VitroL82-G17 (200 μM, 30 min) has selective uncompetitive inhibitory effect for LigI. L82-G17 (0-100 μM) increases LigI binding to non-ligatable nicked DNA binding.L82-G17 inhibits step 3 of the ligation reaction, phosphodiester bond formation.L82-G17 (0-100 μM) inhibits DNA synthesis, cell viability and s induces DNA damage. Cell Viability Assay Cell Line:HeLa cells Concentration:0-30 μM Incubation Time:5 days Result:Reduced cell number by about 70% at 20 μM.Cell Proliferation Assay Cell Line:CH12F3 WT and CH12F3Δ/Δ cells Concentration:0-100 μM Incubation Time:72 h Result:Had great effect on the proliferation and survival of the parental CH12F3 cells.
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorFGFR2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number92285-87-5
-
Formula Weight264.67
-
Molecular FormulaC11H9ClN4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (472.29 mM)
-
SMILESOC1=CC=CC(\C=N\NC2=C(Cl)C(=O)NN=C2)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lescarbeau, Andre, et al. Preparation of substituted pyrrolopyrimidines as FGFR inhibitors and methods of making and using the same. WO2022109577.
molnova catalog
related products
-
2'-Deoxyuridine
2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis.
-
Laromustine
Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity.
-
Mechlorethamine hydr...
Mechlorethamine hydrochloride is a vesicant and necrotizing irritant destructive to mucous membranes.
Cart
sales@molnova.com